Despite the use of today’s preventive measures, VTE still happens. It’s still the monkey on your back.

For many post–orthopedic surgical patients, venous thromboembolism (VTE) poses a significant health risk. VTE consists of 2 potentially life–threatening conditions :
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)

These conditions can lead to long-term complications.

CONCERTA is a once-daily methylphenidate product that provides efficacy through 12 hours with one morning dose. Using proprietary OROS® delivery, CONCERTA is the only ADHD therapy that provides a gradual ascending release of methylphenidate throughout the day.

Now, not only can children and adolescents with ADHD benefit from CONCERTA – adults with ADHD can too. CONCERTA is now approved by FDA for adults with ADHD, based on clinical trials with over 1,000 patients.